Biodefense Market (By Product: Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others)- Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

CHAPTER 1. Industry Overview of Biodefense
1.1. Definition and Scope 
1.1.1. Definition of Biodefense
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Biodefense Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Biodefense Market By Product
1.2.3. Biodefense Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Biodefense Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Biodefense Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Biodefense Market By Product
4.1. Introduction
4.2. Biodefense Revenue By Product
4.2.1. Biodefense Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Anthrax  
4.2.2.1. Anthrax Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Smallpox  
4.2.3.1. Smallpox Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Botulism
4.2.4.1. Botulism Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Radiation/nuclear
4.2.5.1. Radiation/nuclear Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Others
4.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 5. North America Biodefense Market By Country 
5.1. North America Biodefense Overview
5.2. U.S.
5.2.1. U.S. Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
5.3. Canada
5.3.1. Canada Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
5.4. North America PEST Analysis

CHAPTER 6. Europe Biodefense Market By Country
6.1. Europe Biodefense Market Overview
6.2. U.K.
6.2.1. U.K. Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
6.3. Germany
6.3.1. Germany Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
6.4. France 
6.4.1. France Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
6.5. Spain
6.5.1. Spain Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
6.6. Rest of Europe
6.6.1. Rest of Europe Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
6.7. Europe PEST Analysis

CHAPTER 7. Asia Pacific Biodefense Market By Country
7.1. Asia Pacific Biodefense Market Overview
7.2. China
7.2.1. China Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
7.3. Japan
7.3.1. Japan Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
7.4. India
7.4.1. India Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
7.5. Australia
7.5.1. Australia Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
7.6. South Korea
7.6.1. South Korea Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
7.7. Rest of Asia-Pacific
7.7.1. Rest of Asia-Pacific Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
7.8. Asia Pacific PEST Analysis

CHAPTER 8. Latin America Biodefense Market By Country
8.1. Latin America Biodefense Market Overview
8.2. Brazil
8.2.1. Brazil Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
8.3. Mexico
8.3.1. Mexico Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
8.4. Rest of Latin America
8.4.1. Rest of Latin America Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

CHAPTER 9. Middle East & Africa Biodefense Market By Country 
9.1. Middle East & Africa Biodefense Market Overview
9.2. Saudi Arabia
9.2.1. Saudi Arabia Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3. UAE
9.3.1. UAE Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4. Rest of Middle East & Africa
9.4.1. Rest of Middle East & Africa Biodefense Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027

CHAPTER 10. Player Analysis of Biodefense
10.1. Biodefense Market Company Share Analysis
10.2. Competition Matrix
10.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
10.2.2. New Product Launches and Product Enhancements
10.2.3. Mergers And Acquisition In Global Biodefense Market
10.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 11. Company Profile
11.1. Altimmune Inc. 
11.1.1. Company Snapshot
11.1.2. Business Overview
11.1.3. Financial Overview
11.1.3.1. Revenue (US$ Mn), 2019
11.1.3.2. Altimmune Inc. 2019 Biodefense Business Regional Distribution
11.1.4. Product/ Service and Specification
11.1.5. Recent Developments & Business Strategy
11.1.6. Manufacturing Plant Footprint Analysis
11.2. Bavarian Nordic
11.3. Cleveland BioLabs
11.4. Elusys Therapeutics
11.5. Emergent BioSolutions Inc.
11.6. Ichor Medical Systems
11.7. Ology Bioservices
11.8. PathSensors Inc.
11.9. Siga Technologies Inc.
11.10. Others